
ResistanceBio
ResistanceBio is a YC Winter 2019 (W19) company. Based in Menlo Park, CA, USA; Overland, MO, USA. Team of 15.
About ResistanceBio
Summary
ResistanceBio builds AI-driven drug discovery tools targeting cancer drug resistance. The platform helps researchers and pharmaceutical teams identify why tumors stop responding to treatment and find new therapeutic strategies to overcome it, replacing slow, largely manual preclinical analysis workflows.
From the Y Combinator listing
We solve drug resistance for cancer
Facts
- Healthcare / Healthcare -> Therapeutics
- Menlo Park, CA, USA; Overland, MO, USA
- 15
- Inactive
- Early
Founders (2)
- Christopher Bulow
- Nicholas Goldner
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works